Abstract
Clinical drug trials are public goods and should be publicly funded to avoid undersupply, the suppression of adverse results and other problems, according to Tracy R. Lewis, Jerome H. Reichman and Anthony D. So.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
